Skip to main content
Brenda Hill

Featured Patient Story

Brenda Hill

read more

Latest News Story Headlines

Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneurophathy (ATTRv-PN) through 66 weeks

Published 27 March 2023

read full article
2023 Winter Newsletter

Be sure to catch up on the latest happenings in our winter newsletter here!

read full article
Intellia Presents Updated Interim Data from the Cardiomyopathy Arm of Ongoing Phase 1 Study of NTLA-2001, an Investigational CRISPR Therapy for the Treatment of Transthyretin (ATTR) Amyloidosis at the American Heart Association Scientific Sessions 2022

November 5, 2022

read full article

Calendar & Upcoming Events

Support Group Meeting - New York

The Weill Cornell Medicine Center holds free amyloidosis support group meetings virtually every month.  These groups are led by a medical oncology

view all event details

Amyloidosis Videos

Our Latest Webinar

UPDATES IN ATTR CARDIAC AND NEUROLOGICAL AMYLOIDOSIS: What's new and exciting for 2022 and beyond

Frederick L. Ruberg, MD, Omar K. Siddiqi, MD, K. H. Vincent Lau, and Michelle Kaku, MD – Boston Medical Center/Boston University – Boston, MA

Sign Up for the Latest Updates

Get news from Amyloidosis Foundation
in your inbox

By submitting this form, you are consenting to receive marketing emails from : Amyloidosis Foundation, 7151 N. Main St., Suite 2, Clarkston, MI, 48346, US, https://www.amyloidosis.org. You can revoke your consent to receive emails at any time by using SafeUnsubscribe© link, found at the bottom of every email. Emails are serviced by Constant Contract.